Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-17
    E.g., 2018-10-17

Archive Search

1 results
12:00 AM, May 25, 2015  |  BioCentury | Strategy

You better you bet

genotypes. Blatt said J&J would start Phase II combination studies of ACH-3102 with Olysio and AL-335
and/or AL-516. AL-335 is a uridine-based nucleotide analog, which Blatt said has shown activity against all …